- ICH GCP
- Yhdysvaltain kliinisten tutkimusten rekisteri
- Kliininen tutkimus NCT05326750
Ei-invasiivinen neurostimulaatio työkaluna neurodegeneratiivisten sairauksien diagnostiikkaan ja hoitoon
Double blinded, sham-controlled, randomized trial on repeated transcranial alternating current brain stimulation (tACS) in neurodegenerative diseases. The investigators will evaluate whether a 4-times daily repeated stimulation with gamma tACS on the posterior parietal cortex can improve symptoms in patients with neurodegenerative diseases, including dementia with Lewy Bodies, Alzheimer's disease, idiopathic normal pressure hydrocephalus and Frontotemporal dementia.
Tutkimuksen yleiskatsaus
Tila
Interventio / Hoito
Yksityiskohtainen kuvaus
Double blinded, sham-controlled, randomized trial on repeated transcranial alternating current brain stimulation (tACS) in neurodegenerative diseases. The investigators will evaluate whether a 4-times daily repeated stimulation with gamma tACS on the posterior parietal cortex can improve symptoms in patients with neurodegenerative diseases, including dementia with Lewy Bodies, Alzheimer's disease, idiopathic normal pressure hydrocephalus and Frontotemporal dementia.
Opintotyyppi
Ilmoittautuminen (Arvioitu)
Vaihe
- Ei sovellettavissa
Yhteystiedot ja paikat
Opiskeluyhteys
- Nimi: Eino Solje, MD, PhD
- Puhelinnumero: +358 17 713 311
- Sähköposti: eino.solje@uef.fi
Opiskelupaikat
-
-
-
Kuopio, Suomi
- Rekrytointi
- Kuopio University Hospital
-
Ottaa yhteyttä:
- Eino Solje
-
-
Osallistumiskriteerit
Kelpoisuusvaatimukset
Opintokelpoiset iät
Hyväksyy terveitä vapaaehtoisia
Sukupuolet, jotka voivat opiskella
Kuvaus
Inclusion Criteria:
- Mild Cognitive Impairment due to Alzheimer's disease
- Dementia with Lewy Bodies
- Frontotemporal dementia
- Idiopathic normal pressure hydrocephalus (iNPH)
Exclusion Criteria:
- History of seizures
- Pregnancy
- Metal implants in the head (except dental fillings)
- Electronic implants (i.e. pace-maker, implanted medical pump)
- Age <18 years
Opintosuunnitelma
Miten tutkimus on suunniteltu?
Suunnittelun yksityiskohdat
- Ensisijainen käyttötarkoitus: Hoito
- Jako: Satunnaistettu
- Inventiomalli: Rinnakkaistehtävä
- Naamiointi: Nelinkertaistaa
Aseet ja interventiot
Osallistujaryhmä / Arm |
Interventio / Hoito |
|---|---|
|
Kokeellinen: Real tACS
Four sessions (once a day, during four consecutive days) of gamma tACS (40 Hz) at 3 mA over the superior parietal cortex (Precuneus) |
Single session of gamma tACS (40 Hz) over the superior parietal cortex |
|
Placebo Comparator: Sham tACS
Four sessions of sham tACS (once a day, during four consecutive days) over the superior parietal cortex (Precuneus) |
Single session of gamma tACS (40 Hz) over the superior parietal cortex |
Mitä tutkimuksessa mitataan?
Ensisijaiset tulostoimenpiteet
Tulosmittaus |
Toimenpiteen kuvaus |
Aikaikkuna |
|---|---|---|
|
Changes in Rey Auditory Verbal Learning Test score
Aikaikkuna: Baseline (immediately before the intervention), immediately after the first intervention, immediately after the 4th intervention, 4 weeks after the last intervention
|
Participants are given a list of 15 unrelated words repeated over five different trials and are asked to repeat. Another list of 15 unrelated words are given and the patient must again repeat the original list of 15 words and then again after 30 minutes. The examiner reads aloud 15 unrelated words and the participant is asked to recall the words after each of the five trials. After a 15 minute delay, the participant is asked again to recall the words. The score ranges from 0 (worst performance) to 75 (best performance). |
Baseline (immediately before the intervention), immediately after the first intervention, immediately after the 4th intervention, 4 weeks after the last intervention
|
|
Changes in Rey Auditory Verbal Learning Test, recognition
Aikaikkuna: Baseline (immediately before the intervention), immediately after the first intervention, immediately after the 4th intervention, 4 weeks after the last intervention
|
Participants are given a list of 15 unrelated words repeated over five different trials and are asked to repeat. After a 15 minute delay, the participant is asked to recognise the original 15 words intermixed with 31 distractor words. The score of the recognition part ranges from 0 (worst performance) to 46 (best performance). |
Baseline (immediately before the intervention), immediately after the first intervention, immediately after the 4th intervention, 4 weeks after the last intervention
|
|
Changes in orientation to time and place (MMSE questions 1-10)
Aikaikkuna: Baseline (immediately before the intervention), immediately after the last intervention, 4 weeks after the last intervention
|
10 questions about the orientation. The score ranges from 0 (worse performance) to 10 (best performance). |
Baseline (immediately before the intervention), immediately after the last intervention, 4 weeks after the last intervention
|
|
Changes in Trail Making A & B tests
Aikaikkuna: Baseline (immediately before the intervention), immediately after the 4th intervention, 4 weeks after the last intervention
|
TMT A & B tests. Time to perform set is recorded. |
Baseline (immediately before the intervention), immediately after the 4th intervention, 4 weeks after the last intervention
|
|
Changes in INECO Frontal Screening test
Aikaikkuna: Baseline (immediately before the intervention), immediately after the 4th intervention, 4 weeks after the last intervention
|
Test battery assessing frontal lobe functions. The score ranges from 0 (worse performance) to 30 (best performance) |
Baseline (immediately before the intervention), immediately after the 4th intervention, 4 weeks after the last intervention
|
|
Changes in phonemic fluency
Aikaikkuna: Baseline (immediately before the intervention), immediately after the first intervention, immediately after the 4th intervention, 4 weeks after the last intervention
|
Person is requested to provide as many words as possible starting with certain letter. The score is the sum of all acceptable words produced in one minute. |
Baseline (immediately before the intervention), immediately after the first intervention, immediately after the 4th intervention, 4 weeks after the last intervention
|
Toissijaiset tulostoimenpiteet
Tulosmittaus |
Toimenpiteen kuvaus |
Aikaikkuna |
|---|---|---|
|
Change in SAI measurements
Aikaikkuna: Baseline (immediately before the intervention), immediately after the last intervention
|
By using transcranial magnetic stimulation (TMS), the investigators will evaluate the effects of gamma tACS on short latency afferent inhibition (SAI), which is a marker of cholinergic neurotransmission. |
Baseline (immediately before the intervention), immediately after the last intervention
|
|
Change in SICI measurements
Aikaikkuna: Baseline (immediately before the intervention), immediately after the last intervention
|
By using transcranial magnetic stimulation (TMS), the investigators will evaluate the effects of gamma tACS on short interval intracortical inhibition (SICI), which is a marker of gabaergic neurotransmission. |
Baseline (immediately before the intervention), immediately after the last intervention
|
|
Change in ICF measurements
Aikaikkuna: Baseline (immediately before the intervention), immediately after the last intervention
|
By using transcranial magnetic stimulation (TMS), the investigators will evaluate the effects of gamma tACS on intracortical facilitation (ICF), which is a marker of glutamatergic neurotransmission. |
Baseline (immediately before the intervention), immediately after the last intervention
|
|
Change in modified Frontal Behavioral Inventory (FBI-mod) score
Aikaikkuna: Baseline (immediately before the intervention), immediately after the last intervention, 4 weeks after the last intervention
|
The modified Frontal Behavioral Inventory (FBI-mod) is used to assess behavioral symptoms associated with frontotemporal dysfunction. The questionnaire evaluates changes in behavioral and personality features. Higher scores indicate a greater severity of behavioral symptoms. |
Baseline (immediately before the intervention), immediately after the last intervention, 4 weeks after the last intervention
|
|
Change in Neuropsychiatric Inventory (NPI) score
Aikaikkuna: Baseline (immediately before the intervention), immediately after the last intervention, 4 weeks after the last intervention
|
The Neuropsychiatric Inventory (NPI) is used to assess neuropsychiatric symptoms, including their frequency and severity. Higher total scores indicate a greater burden of neuropsychiatric symptoms. |
Baseline (immediately before the intervention), immediately after the last intervention, 4 weeks after the last intervention
|
Yhteistyökumppanit ja tutkijat
Sponsori
Tutkijat
- Päätutkija: Eino Solje, MD, PhD, Kuopio University Hospital
Opintojen ennätyspäivät
Opi tärkeimmät päivämäärät
Opiskelun aloitus (Todellinen)
Ensisijainen valmistuminen (Arvioitu)
Opintojen valmistuminen (Arvioitu)
Opintoihin ilmoittautumispäivät
Ensimmäinen lähetetty
Ensimmäinen toimitettu, joka täytti QC-kriteerit
Ensimmäinen Lähetetty (Todellinen)
Tutkimustietojen päivitykset
Viimeisin päivitys julkaistu (Todellinen)
Viimeisin lähetetty päivitys, joka täytti QC-kriteerit
Viimeksi vahvistettu
Lisää tietoa
Tähän tutkimukseen liittyvät termit
Muita asiaankuuluvia MeSH-ehtoja
- Synukleinopatiat
- Aivojen sairaudet
- Keskushermoston sairaudet
- Hermoston sairaudet
- Mielenterveyshäiriöt
- Metaboliset sairaudet
- Neurokognitiiviset häiriöt
- Dementia
- Tauopatiat
- Neurodegeneratiiviset sairaudet
- Liikkumishäiriöt
- Parkinsonin häiriöt
- Basal ganglia -taudit
- TDP-43 Proteinopatiat
- Proteostaasin puutteet
- Frontotemporaalinen lobarin rappeuma
- Ravitsemukselliset ja aineenvaihduntataudit
- Alzheimerin tauti
- Frontotemporaalinen dementia
- Lewyn kehon sairaus
Muut tutkimustunnusnumerot
- KUH5772859
Yksittäisten osallistujien tietojen suunnitelma (IPD)
Aiotko jakaa yksittäisten osallistujien tietoja (IPD)?
IPD-suunnitelman kuvaus
Pseudonymized data upon request, according to Finnish national and EU GDPR regulations
IPD-jaon aikakehys
Data will be shared after the study completion indefinitely.
IPD-jaon käyttöoikeuskriteerit
Reasonable request
Lääke- ja laitetiedot, tutkimusasiakirjat
Tutkii yhdysvaltalaista FDA sääntelemää lääkevalmistetta
Tutkii yhdysvaltalaista FDA sääntelemää laitetuotetta
Nämä tiedot haettiin suoraan verkkosivustolta clinicaltrials.gov ilman muutoksia. Jos sinulla on pyyntöjä muuttaa, poistaa tai päivittää tutkimustietojasi, ota yhteyttä register@clinicaltrials.gov. Heti kun muutos on otettu käyttöön osoitteessa clinicaltrials.gov, se päivitetään automaattisesti myös verkkosivustollemme .